is tirzepatide oral or injectable vs Injection: Which Better? sublingual vs injectable tirzepatide Oral

Overall, about one in five (22%) adults who are not currently taking GLP-1 drugs (88% of the public) say they would be interested in taking a GLP-1 drug to lose weight, including just 7% who say they would be very interested. This rises to four in ten (43%) among adults who are not currently taking a GLP-1 but report being diagnosed as overweight or obese in the past five years, and about one in four (27%) among those who say they have been diagnosed with diabetes or heart disease

Your clinician picks up where your last provider left off same dose, no gap in treatment

Gee started taking Wegovy in 2023 and has lost over 50 pounds

Ozempic (semaglutide) is a GLP-1 receptor agonist for type 2 diabetes

4